Abstract
The temporal relationship between the onset of Graves’ ophthalmopathy and the onset of thyroidal Graves’ disease was evaluated in 125 consecutive patients with Graves’ ophthalmopathy. Thyroidal Graves’ disease — past or present — was clinically evident in 99 patients (79%): hyperthyroidism in 96 and hypothyroidism in 3 cases. Thyroid disease preceded the eye disease in 37 patients, it occurred simultaneously with the eye disease in 39 patients, and it developed after the eye disease in 23 patients (in 16 cases within one yr after the onset of eye disease). The age at the onset of thyroid disease (38.7 ± 12.9 yr) was lower than the age at the onset of ophthalmopathy (41.8 ± 12.5 yr; p< 0.001). Among the 26 clinically euthyroid patients (21%) laboratory evidence of thyroidal Graves’ disease was found in 14 cases (11%): abnormal TRH test, n = 9; normal TRH test but abnormal T3-suppression test, n = 4; normal TRH and T3-suppression tests but positive thyroid stimulating antibodies, n = 1). We conclude that Graves’ ophthalmopathy as a rule develops at a time when thyroid autoimmunity also exists. This strongly suggests a common factor in the pathogenesis of thyroidal and ocular expressions of Graves’ disease.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Jacobson D.H., Gorman C.A. Endocrine ophthalmopathy: current ideas concerning etiology, pathogenesis and management. Endocr. Rev. 5: 200, 1984.
Hall R., Ford J., Manson N. Ophthalmic Graves’ disease. In: Irvine W.J. (Ed.), Thyrotoxicosis. Proceedings of an International Symposium. Livingstone, Edinburgh, p. 210.
Solomon D.H., Chopra I.J., Chopra U., Smith F.J. Identification of subgroups of euthyroid Graves’ ophthalmopathy. N.Engl. J. Med. 296: 181, 1977.
Gorman C. Ophthalmopathy of Graves’ disease. N. Engl. J. Med. 308: 453, 1983.
Wiersinga W.M. Conceptual evolution in the relationship between Graves’ ophthalmopathy and Graves’ disease. Orbit 3: 213, 1984.
Franco P.S., Hershman J.M., Haigler Jr. E.D., Pitman J.A. Response to thyrotropin-releasing hormone compared with thyroid suppression test in euthyroid Graves’ disease. Metabolism 22: 1357, 1973.
Ormston B.J., Alexander L., Evered D.C., Clark F., Bird T., Appleton D., Hall R. Thyrotropin response to thyrotropin-releasing hormone in ophthalmic Graves’ disease: correlation with other aspects of thyroid function, thyroid suppressibility and activity of eye signs. Clin. Endocrinol. (Oxf.) 2: 369, 1973.
Werner S.C. Modification of the classification of the eye changes of Graves’ disease: recommendations of the ad hoc committee of the American Thyroid Association. J. Clin. Endocrinol. Metab. 44: 203, 1977.
Wiersinga W.M., Touber J.L. Thyroid function tests II. Studies in patients with thyroid diseases. Neth.J. Med. 23: 200, 1980.
Burke G. The triiodothyronine suppression test. Am. J. Med. 42: 600, 1967.
Wall J.R. Autoimmunity and Graves’ ophthalmopathy. In: Gorman C.A., Waller R.R., Dyer J.A. (Eds.), The eye and orbit in thyroid disease. Raven Press, New York, 1984, p. 103.
Brownlie B.E.W., Newton O.A.G., Singh S.P. Ophthalmopathy associated with primary hypothyroidism. Acta Endocrinol. (Kbh.) 79: 691, 1975.
Tamai H., Nakagana T., Ohsako N., Fukino O., Takahashi H., Matsuzurka F., Kuma K., Nagataki S. Changes in thyroid functions in patients with euthyroid Graves’ disease. J. Clin. Endocrinol. Metab. 50: 108, 1980.
Yamamoto K., Itoh K., Yoshida S., Saito K., Sokamoto Y., Matsuda A., Saito T., Kuzya T. A quantitative analysis of orbital soft tissue in Graves’ disease based on B-mode ultrasonography. Endocrinol. Jpn. 26: 255, 1979.
Amino N., Yuasa T., Yabu Y., Miyai K., Kumahara Y. Exophthalmus in autoimmune thyroid disease. J. Clin. Endocrinol. Metab. 51: 1232, 1980.
Werner S.C., Coleman D.J., Franzen L.A. Ultrasonographic evidence of a consistent orbital involvement in Graves’ disease. N. Engl. J. Med. 290: 1447, 1974.
Forrester J.V., Sutherland F.R., McDougall J.R. Dysthyroid ophthalmopathy: orbital evaluation with B-scan ultrasonography. J. Clin. Endocrinol. Metab. 45: 221, 1977.
Gamblin G.T., Harper D.G., Galentine P., Buck D.R., Chernow B., Eil C. Prevalence of increased ocular pressure in Graves’ disease: evidence of frequent subclinical ophthalmopathy. N. Engl. J. Med. 308: 420, 1983.
Gorman C.A. Temporal relationship between onset of Graves’ ophthalmopathy and diagnosis of thyrotoxicosis. Mayo Clin. Proc. 58: 515, 1983.
Atkinson S., Holcombe M., Kendall-Taylor P. Ophthalmopathic immunoglobulins in patients with Graves’ ophthalmopathy. Lancet 2: 374, 1984.
Faryna M., Nauman J., Gardas A. Measurement of autoantibodies against human eye muscle plasma membranes in Graves’ ophthalmopathy. Br. Med. J. 290: 191, 1985.
Volpé R. The pathogenesis of Graves’ disease: an overview. Clin. Endocrinol. Metab. 7: 3, 1978.
Bizzarro A., Cennamo G., Bonavolonta G. T-lymphocyte subsets in euthyroid Graves’ ophthalmopathy. Orbit 3: 223, 1984.
Kuroki T., Ruf J., Whelan L., Miller A., Wall J.R. Antithyroglobulin monoclonal and autoantibodies cross-react with an orbital consecutive tissue membrane antigen: a possible mechanism for the association of ophthalmopathy with autoimmune thyroid disorders. Clin. Exp. Immunol. 62: 361, 1985.
Rotella C.M., Zonefrati R., Toccafondi R., Valente W.A., Kohn L.D. Ability of monoclonal antibodies to the thyrotropin receptor to increase collagen synthesis in human fibroblasts: an assay which appears to measure exophthalmogenic immunoglobulins in Graves’ sera. J. Clin. Endocrinol. Metab. 62: 357, 1986.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wiersinga, W.M., Smit, T., van der Gaag, R. et al. Temporal relationship between onset of Graves’ ophthalmopathy and onset of thyroidal Graves’ disease. J Endocrinol Invest 11, 615–619 (1988). https://doi.org/10.1007/BF03350193
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03350193